The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Endocannabinoids–at the crossroads between the gut microbiota and host metabolism
Abstract
Various metabolic disorders are associated with changes in inflammatory tone. Among the latest advances in the metabolism field, the discovery that gut microorganisms have a major role in host metabolism has revealed the possibility of a plethora of associations between gut bacteria and numerous diseases. However, to date, few mechanisms have been clearly established. Accumulating evidence indicates that the endocannabinoid system and related bioactive lipids strongly contribute to several physiological processes and are a characteristic of obesity, type 2 diabetes mellitus and inflammation. In this Review, we briefly define the gut microbiota as well as the endocannabinoid system and associated bioactive lipids. We discuss existing literature regarding interactions between gut microorganisms and the endocannabinoid system, focusing specifically on the triad of adipose tissue, gut bacteria and the endocannabinoid system in the context of obesity and the development of fat mass. We highlight gut-barrier function by discussing the role of specific factors considered to be putative 'gate keepers' or 'gate openers', and their role in the gut microbiota-endocannabinoid system axis. Finally, we briefly discuss data related to the different pharmacological strategies currently used to target the endocannabinoid system, in the context of cardiometabolic disorders and intestinal inflammation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ECS and GM interact to regulate intestinal homeostasis resulting in relevant functional effects in the gut and CNS (238, 246, 248, 250).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [238]
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Linking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–367 of 367
Divín, D., Toman, J., Jaroslav Flegr, A., & Vinkler, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-67489-6 · Cited by 2
“While improved hygiene and medical care decreased mortality due to microbial infections, the modern societies are experiencing a continuous increase in prevalence of allergies, autoimmune and chronic inflammatory diseases, as well as psychiatric and metabolic disorders 27–30 .”
Dysbiosis of gut microbiota and human diseases
Huidrom, S., & Beg, M. A. (2020) · Journal of Mahatma Gandhi Institute of Medical Sciences · doi:10.4103/jmgims.jmgims_59_19 · Cited by 2
Targeting the gut to treat obesity and its metabolic consequences: view from the Chair
Sharkey, K. A. (2016) · International Journal of Obesity Supplements · doi:10.1038/ijosup.2016.2 · Cited by 2
Wiącek, J., Skonieczna‐Żydecka, K., Łoniewski, I., Deli, C. K., Fatouros, I. G., Jamurtas, A. Z., Moszczyńska, D., & Karolkiewicz, J. (2025) · Microorganisms · doi:10.3390/microorganisms13061284 · Cited by 1
“The endocannabinoid system (ECS) and gut microbiota interact bidirectionally: microbiota alterations affect ECS-regulated processes, such as inflammation, energy balance, and gut barrier function, while ECS activity can shape microbial composition [15].”
Jasielczuk, I., Oclon, E. A., Żurowski, J., Szmatoła, T., Mizera-Szpilka, K., & Gurgul, A. (2025) · Current Genetics · doi:10.1007/s00294-025-01327-8 · Cited by 1
“…more, CBD can directly affect the intestines (Izzo and Sharkey 2010 ); Trautmann and Sharkey 2015 ) by inter-acting with the intestinal microflora (Cani et al. 2016), regulating intestinal permeability (Muccioli et al. 2010), modulation of immune responses (Nagarkatti et al. 2009 ), and effects…”
Wang, W., Feng, C., Lou, Y., Liu, C., Chang, G., Xu, K., Ren, W., Luo, M., Hu, Y., & Zhu, L. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107325 · Cited by 1
Giorgini, G., Mir, H.-D., Etienne, C., Dumais, E., Maximin, E., Silvestri, C., Flamand, N., Naudon, L., Rabot, S., & Marzo, V. D. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101070 · Cited by 1
“…here by E. coli colonization, thus reinforcing the concept of the multiplicity of gut microbiota regulation of the eCBome, exemplified also by the fact that other commensal bacteria-derived metabolites, as well as several probiotic strains, can alter this signaling system (12, 21, 54, 63).”
Diet, microbiota, and lipidomics: How fatty acids shape the endocannabinoidome and host metabolism
Petrosino, S., Fontecilla-Escobar, J., Marzo, V. D., & Iannotti, F. A. (2026) · Progress in Lipid Research · doi:10.1016/j.plipres.2026.101396 · Cited by 2
Microbiome and Immunity: A Critical Link for Long-Duration Space Exploration Missions
Lorenzi, H. (2019) · Springer eBooks · doi:10.1007/978-3-030-16996-1_34 · Cited by 1
Anggriany, N., Noer, E. R., Margawati, A., Pramono, A., & Anjani, G. (2024) · Journal of Nutrition College · doi:10.14710/jnc.v13i3.42821 · Cited by 1
“Elucidating the immunomodulatory role of endocannabinoids in intervertebral disc degeneration”
Vasudevan, G., Ramachandran, K., Tangavel, C., Nayagam, S. M., Gopalakrishnan, C., Raveendran, M., Anand, K. S. S. V., & Rajasekaran, S. (2024) · European Spine Journal · doi:10.1007/s00586-024-08550-w · Cited by 1
Piantedosi, D., Giada, M., Musco, N., Carlo, S., della Valle, M. F., Francesco, P., Saad, N., Giulia, A., Maria, F., Lombardi, P., et al. (2025) · BMC Veterinary Research · doi:10.1186/s12917-025-04946-y · Cited by 1
Oudat, Q., Al-Qudah, M. A. M. S., & Ababneh, D. (2019) · International Healthcare Research Journal · doi:10.26440/ihrj/0303.06240 · Cited by 1
Akkermansia mucinifila and the part that it plays in metabolic disturbance
Fadieienko, G. D., & Gridnyev, O. (2020) · Ukrainian Therapeutical Journal · doi:10.30978/utj2020-4-55 · Cited by 1
Minichino, A., Jackson, M. A., Francesconi, M., Steves, C. J., Menni, C., Burnet, P. W. J., & Lennox, B. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.01.039 · Cited by 1
Impact of Precision Nutrition on Microbiota and Obesity
Merra, G., Gualtieri, P., LORENZO, A. D., Capacci, A., Frank, G., Dri, M., Renzo, L. D., & Marchetti, M. (2023) · Current Nutrition & Food Science · doi:10.2174/1573401319666230724112531 · Cited by 1
Costiniuk, C. T., & Jenabian, M.-A. (2020) · AIDS · doi:10.1097/qad.0000000000002481 · Cited by 1
Immunoregulatory Mechanisms in a Mouse Model of Hookworm Infection
Batugedara, H. (2018) · eScholarship (California Digital Library)
Targeting the endocannabinoid system: future therapeutic strategiesPreprint
Aizpurua‐Olaizola, O., Elezgarai, I., Rico‐Barrio, I., Zarandona, I., Etxebarría, N., & Usobiaga, A. (2017) · viXra · doi:10.6084/m9.figshare.5028362
Chemistry and Enzymology Encoded by the Human Microbiome
Shine, E. E., Nwe, P.-K., & Crawford, J. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.14659-1
The endocannabinoid system: from the receptors to therapy
Bába, L.-I., Kolcsár, M., Beatrix, H., Gáll, Z., & Zoltán, K. I. (2019) · Orvostudományi Értesítö · doi:10.2478/orvtudert-2019-0002
“Azóta egy sor más, az ECR-el kapcsolatos gén kifejeződését hozták összefüggésbe a bélflórával (NAPE-PLD, CB1, FAAH) [61].”
Wang, P., Li, C., Seshadri, S., & Liu, J. (2020) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2020.19755
Cannabinoid Receptor and InflammationPreprint
Osafo, N., Yeboah, K. O., Antwi, A. O., & Ainooson, G. K. (2020) · doi:10.22541/au.159986420.00633539 · Cited by 1
Contribution of microbiota in the pathogenesis of ischemic stroke
Farooqui, A. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821039-0.00007-1
Is fecal microbiota transplantation a promising strategy for type 2 diabetes mellitus?
Yang, Z. (2020) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2020.08.00275
Divín, D., Gómez-Samblás, M., Veetil, N. K., Voukali, E., Świderská, Z., Krajzingrová, T., Těšičký, M., Beneš, V., Elleder, D., Bartoš, O., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.03.474805
Cotter, P. D., & Barton, W. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733609799.793567418
Bockaert, J. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.730126536.793537627
Tarasiuk, A., Sałaga, M., & Fichna, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65635-0
Normal Microbiome of the Oral Cavity
Kheur, S. M., Acharya, A., Kheur, M., Jain, V. K., & Hazarey, V. K. (2022) · Springer eBooks · doi:10.1007/978-981-19-0592-6_6
Advances in the Study of Intestinal Flora-Cannabinoid System and Premature Ejaculation
郑, 俊. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.1291200
Research Progress of Thirst and Oral Dry after Drinking Alcohol
胡, 郑. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.131008
Scheithauer, T. P. M. (2023) · doi:10.5463/thesis.82
Jin, D., Hao, J., Chen, Y., Guo, Y., Chen, L.-W., Chao, S., Zhou, L., Ye, D., Zhu, H., Dai, X., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3034344/v1
Microbiome variations induced by delta9-tetrahydrocannabinol predict weight reduction in obese mice
Kaye, A. G., Rusling, M., Dhopeshwarkar, A., Kumar, P., Wagment-Points, L., Mackie, K., & Yuan, L. (2024) · Frontiers in Microbiomes · doi:10.3389/frmbi.2024.1412468
Anandamide: From modulation of neuronal excitation to antimicrobial activities—What is in common?
Sionov, R. V., & Steinberg, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19081-0.00017-2
Marousez, L., Dumais, E., Tran, L. C., Dubernat, L., de Lamballerie, M., Gottrand, F., Ley, D., Flamand, N., Marzo, V. D., & Lésage, J. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1558524
“For example, when the eCB system is activated, a disruption of the gut barrier, a low-grade in fl ammation and an increased adipogenesis are observed (37, 38).”
Role of Gut-Liver Axis in Non-Alcoholic Fatty Liver Disease: A Mini Review
Yaghmaei, H., Taromiha, A., Nojoumi, S. A., Soltanipur, M., Shahshenas, S., Rezaei, M., Mirhosseini, S. M., Hosseini, S. M., & Siadat, S. D. (2025) · Iranian Biomedical Journal · doi:10.61882/ibj.4212 · Cited by 1
Bourdeau‐Julien, I., Castonguay-Paradis, S., Rochefort, G., Perron, J., Lamarche, B., Flamand, N., Di Marzo, V., Veilleux, A., & Raymond, F. (2023) · Figshare · doi:10.6084/m9.figshare.22615424
Bourdeau‐Julien, I., Castonguay-Paradis, S., Rochefort, G., Perron, J., Lamarche, B., Flamand, N., Di Marzo, V., Veilleux, A., & Raymond, F. (2023) · Figshare · doi:10.6084/m9.figshare.22615421
Bristot, V. J. D. O., Poletto, G. S. F., Pereira, D. M. R., Hauck, M., Schneider, I. J. C., & Junior, A. S. A. (2022) · Figshare · doi:10.6084/m9.figshare.19793375
Bourdeau‐Julien, I., Castonguay-Paradis, S., Rochefort, G., Perron, J., Lamarche, B., Flamand, N., Di Marzo, V., Veilleux, A., & Raymond, F. (2023) · Figshare · doi:10.6084/m9.figshare.22615418
Bourdeau‐Julien, I., Castonguay-Paradis, S., Rochefort, G., Perron, J., Lamarche, B., Flamand, N., Di Marzo, V., Veilleux, A., & Raymond, F. (2023) · Figshare · doi:10.6084/m9.figshare.22615427
Bourdeau‐Julien, I., Castonguay-Paradis, S., Rochefort, G., Perron, J., Lamarche, B., Flamand, N., Di Marzo, V., Veilleux, A., & Raymond, F. (2023) · Figshare · doi:10.6084/m9.figshare.22615415
Bourdeau‐Julien, I., Castonguay-Paradis, S., Rochefort, G., Perron, J., Lamarche, B., Flamand, N., Di Marzo, V., Veilleux, A., & Raymond, F. (2023) · Figshare · doi:10.6084/m9.figshare.22615430
Bristot, V. J. D. O., Poletto, G., Pereira, D. M. R., Hauck, M., Schneider, I. J. C., & Junior, A. S. A. (2022) · Figshare · doi:10.6084/m9.figshare.19793378
Taye, I., Bradbury, J., & Grace, S. (2026) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-05187-0
Research progress on the role of gut microbiota in skeletal muscle atrophy
Wen-Ya, G. U. O., XIANG, S.-J., ZHANG, X.-L., Yao, L., & Li, Y. (2026) · Shengming kexue · doi:10.3724/cbls.2026011
Beraldi, E. J., Habibyan, Y. B., Keenan, C. M., Wallace, L. E., & Sharkey, K. A. (2026) · Scientific Reports · doi:10.21203/rs.3.rs-8854797/v1
Fibrose intestinale, récepteur minéralocorticoide,alimentation.
Leboutte, M. (2023) · theses.fr (ABES) · doi:10.70675/a47cb697z212az4a17za4d6zeaf9d5cbaf24
Gut microbiota and osteoarthritis
Minasov, T. B., Zagorodniy, N. V., Алексеева, Л. И., Александровна, Т. Е., Yakupova, E. R., Плакун, В. М., Saubanov, R. A., Glazunov, S. Y., Kabirov, R. D., Matnurov, D. I., et al. (2026) · Vrač skoroj pomoŝi (Emergency Doctor) · doi:10.33920/med-02-2603-01
Matrix Matters: ECM Remodeling in Bone Disease Progression
Dash, P., Patra, K., Jena, I., Bhadra, L., & Dash, M. (2026) · Biology of extracellular matrix · doi:10.1007/978-3-032-22618-1_2
Daikenchuto modulates gut microbial metabolism to mitigate irinotecan-induced enterotoxicityPreprint
Xu, Y., Liang, R., Xia, P., Luo, S., Jiang, B., Wang, A., Liang, K., Wang, Y., Jing, W., & Wang, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.727323
Łukowski, W. (2026) · Frontiers in Natural Products · doi:10.3389/fntpr.2026.1812441
Microbiota and lipid mediators: from molecular crosstalk to therapeutic opportunities
Gökcen, B. B., Atabılen, B., Güneş, B. D., Dazıroğlu, M. E. Ç., Özer, Ş. D., Biten, A. A., Pagano, E., Nanì, M. F., Romano, B., Ağagündüz, D., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1836931
“ECS primarily includes type 1 and 2 cannabinoid receptors (CB1 and CB2), lipid-derived endogenous ligands, and the enzymes responsible for the synthesis and degradation of these ligands (Cani et al., 2016).”
Cannabis and liver health: exploring the gut-liver axis and the role of the gut microbiota
Balakrishnan, J., Kannan, S., Ramasamy, M., Datchanamurthy, B., & Nagarajan, P. (2026) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2026.101127
O’Brien, K., & Blair, P. (2026) · Springer eBooks · doi:10.1007/978-3-032-14521-5_10
Huang, Y., Zhang, J., Yu, H., Yang, H., & Chen, M. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70585
The endocannabinoidome–microbiota axis in obesity: a potential link to colorectal cancer development
Alpino, G. D. C. Á., Brasiel, P. G. D. A., Almeida, M. M., & Luquetti, S. C. P. D. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01225-8
“The endocannabinoid-related mediators 2-oleoylglycerol (2-OG), palmitoylethanolamide (PEA), and oleoyletha-nolamide (OEA), also act as gatekeepers [ 32–34 ], whereas AEA primarily acts as a “gate opener,” increasing permeability, particularly under inflammatory conditions [ 33, 34 ].”
Mari, M., Rahimi, O., Junior, R. D. A. A., Rocha, B. G. S., Bagaev, A., Sur, D., Begmatova, D., Zemliana, N. A., Boiangiu, A. A., Thanos, P. K., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19091463
“In contrast, Dom dams appeared relatively protected, potentially due to more efficient stress-regulatory mechanisms that may buffer ECS destabilization induced by exogenous cannabinoids, thereby preserving gut microbiota stability [43].”
Falci, M. A., Alpino, G. D. C. Á., Medeiros, J. D., Brasiel, P. G. D. A., de Lima, V. V., Ávila, T. V., Pazos-Moura, C. C., Luquetti, S. C. P. D., Trevenzoli, I. H., & de Almeida, M. M. (2026) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174426100865
“26,27 Similarly, CB2 agonists improve inflammatory bowel disease in vitro and in vivo models.”
Mitchell, M. K., Carty, M. A., Snow, N. L., Archambault, M. T., Budsberg, A. E., Carrillo, E. V., Vignieri, E. E., Older, E. A., Rometo, O. L., van de Wal, L. E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.10.758071
Metadata
- Authors
- Cani, P. D., Plovier, H., Van Hul, M., Geurts, L., Delzenne, N. M., Druart, C., & Everard, A.
- Affiliations
- Walloon Excellence in Lifesciences and Biotechnology (BE)
- UCLouvain (BE)
- Corresponding author
- Cani, Patrice D.
- ORCID
- Venue
- Nature Reviews Endocrinology
- Published
- 2015-12-18
- Volume
- 12
- Issue
- 3
- Pages
- 133-143
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2206708469
- Cited by
- 367
- References
- 156
- Citations by year
- 2026: 23 · 2025: 30 · 2024: 27 · 2023: 37 · 2022: 51 · 2021: 55 · 2020: 45 · 2019: 25 · 2018: 30 · 2017: 24 · 2016: 20
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- endocannabinoid system, gut microbiota, host metabolism, intestinal permeability, intestinal barrier, bioactive lipids, obesity, adipose tissue, type 2 diabetes, cardiometabolic disease, intestinal inflammation, fat mass
- MeSH terms
- Gastrointestinal Microbiome, Animals, Humans, Gastrointestinal Tract, Receptors, Cannabinoid, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
